Zdzierak Barbara, Zasada Wojciech, Krawczyk-Ożóg Agata, Rakowski Tomasz, Bartuś Stanisław, Surdacki Andrzej, Dziewierz Artur
Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, 30-688 Krakow, Poland.
KCRI, 30-347 Krakow, Poland.
J Cardiovasc Dev Dis. 2023 Jan 18;10(2):34. doi: 10.3390/jcdd10020034.
Guidelines recommend using hyperemic (FFR) and non-hyperemic (iFR/RFR) methods of evaluating coronary artery stenoses in patients with coronary artery disease. However, in some cases, achieved results indicating significant ischemia may differ between those methods. Thus, we sought to identify predictors of such a discrepancy. Data were collected on all consecutive patients with chronic coronary syndrome hospitalized between 2020 and 2021. For 279 patients (417 vessels), results for both FFR and iFR/RFR were available. Values of ≤0.80 for FFR and ≤0.89 for iFR/RFR were considered positive for ischemia. Discordant measurements of FFR and iFR/RFR were observed in 80 (19.2%) patients. Atrial fibrillation was the only predictor of the overall FFR and iFR/RFR discordance - OR (95%CI) 1.90 (1.02-3.51); = 0.040. The chance of positive FFR and negative iFR/RFR decreased independently with age - OR (95%CI) 0.96 (0.93-0.99); = 0.024. On the contrary, insulin-treated diabetes mellitus was the predictor of negative FFR and positive iFR/RFR discrepancy - OR (95%CI) 4.61 (1.38-15.40); = 0.013. In everyday clinical practice, iFR/FFR correlates well with FFR. However, discordance between these methods is quite common. Physicians should be aware of the risk of such discordance in patients with atrial fibrillation, advanced age, and insulin-treated diabetes mellitus.
指南建议使用充血(FFR)和非充血(iFR/RFR)方法评估冠心病患者的冠状动脉狭窄。然而,在某些情况下,这些方法得出的表明严重缺血的结果可能有所不同。因此,我们试图确定这种差异的预测因素。收集了2020年至2021年间住院的所有连续性慢性冠状动脉综合征患者的数据。对于279例患者(417支血管),可获得FFR和iFR/RFR的结果。FFR≤0.80和iFR/RFR≤0.89的值被认为缺血阳性。在80例(19.2%)患者中观察到FFR和iFR/RFR测量结果不一致。房颤是FFR和iFR/RFR总体不一致的唯一预测因素——比值比(95%可信区间)为1.90(1.02 - 3.51);P = 0.040。FFR阳性而iFR/RFR阴性的可能性随年龄增长而独立降低——比值比(95%可信区间)为0.96(0.93 - 0.99);P = 0.024。相反,胰岛素治疗的糖尿病是FFR阴性而iFR/RFR阳性差异的预测因素——比值比(95%可信区间)为4.61(1.38 - 15.40);P = 0.013。在日常临床实践中,iFR/FFR与FFR相关性良好。然而,这些方法之间的不一致相当常见。医生应意识到房颤、高龄和胰岛素治疗的糖尿病患者存在这种不一致的风险。